Regorafenib Drug and Market Analysis 2023-2032 with Forecasted Sales Data
January 30, 2024 10:45 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Regorafenib Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report offers a comprehensive...
Colorectal Cancer Diagnostics Market Research Report 2023: Rising Consumer Acceptance of Advanced Therapies Such as Stivarga (regorafenib), Erbitux (cetuximab), & Avastin (bevacizumab) Bolsters Growth
May 04, 2023 07:28 ET
|
Research and Markets
Dublin, May 04, 2023 (GLOBE NEWSWIRE) -- The "Colorectal Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Diagnosis Type, By...
National Brain Tumor Society Invests in GBM AGILE, the World’s First Global Adaptive Trial for Glioblastoma Brain Cancer
January 16, 2019 13:56 ET
|
National Brain Tumor Society
Boston, MA, Jan. 16, 2019 (GLOBE NEWSWIRE) -- National Brain Tumor Society (NBTS), the largest nonprofit dedicated to the brain tumor community in the United States, today announced a partnership...